Changing how we talk about clinical trialsMultiple sclerosis (MS) patient Elizabeth Kinder tells us why she participated in a clinical trial and why the Share XChanging how we talk about clinical trialshttps://pharmaphorum.com/views-analysis-patients/changing-talk-clinical-trials-ms/
J&J strengthens R&D into COVID-19 vaccine with US governmentJohnson & Johnson has announced it has expanded a collaboration with a US government agency to hasten development Share XJ&J strengthens R&D into COVID-19 vaccine with US governmenthttps://pharmaphorum.com/news/jj-strengthens-rd-into-covid-19-vaccine-with-us-government/
Novartis plots cardio trial in UK as London HQ opensNovartis has announced the beginnings of a major cardiovascular outcomes trial in the UK, as it opened a Share XNovartis plots cardio trial in UK as London HQ openshttps://pharmaphorum.com/news/novartis-plots-cardio-trial-in-uk-as-london-hq-opens/
Nearly half of doctors did not discuss trials with cancer patients – surveyAlmost half of cancer patients reported that their medical care team did not discuss clinical trials with them, Share XNearly half of doctors did not discuss trials with cancer patients – surveyhttps://pharmaphorum.com/news/nearly-half-of-doctors-did-not-discuss-trials-with-cancer-patients-survey/
Bridging the gap between global trials and regional processesRegional differences in processes and regulations are compounding the challenges of 21st century clinical trial management. Is greater Share XBridging the gap between global trials and regional processeshttps://pharmaphorum.com/r-d/views-analysis-r-d/bridging-the-gap-between-global-trials-and-regional-processes/
Investigator sponsored trials begin making waves in R&DIncreasing numbers of pharma companies are forgoing CROs to partner with academic centres on investigator sponsored trials (ISTs). Share XInvestigator sponsored trials begin making waves in R&Dhttps://pharmaphorum.com/r-d/views-analysis-r-d/investigator-sponsored-trials-begin-to-make-waves-in-rd/
Making real world evidence fit for purposeAlthough real world evidence (RWE) is a hot topic in pharma right now, many still question whether it Share XMaking real world evidence fit for purposehttps://pharmaphorum.com/views-analysis-market-access/making-real-world-evidence-fit-for-purpose/
Q&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020We spoke to Christian Hebenstreit, senior VP and general manager, EMEA at Medidata, a Dassault Systèmes company, to Share XQ&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020https://pharmaphorum.com/r-d/views-analysis-r-d/qa-medidatas-christian-hebenstreit-on-clinical-trials-trends-for-2020/
Four ways AI and machine learning will transform healthcare in 2020From AI assisted robotic surgery to clinical diagnosis, image analysis and administrative tasks, the use of artificial intelligence Share XFour ways AI and machine learning will transform healthcare in 2020https://pharmaphorum.com/digital/four-ways-ai-and-machine-learning-will-transform-healthcare-in-2020/
